Cited by 586Renin-Angiotensin System StudiesAtherosclerosis and Cardiovascular DiseasesNitric Oxide and Endothelin Effects

The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.

Vascular Inflammation and the Renin-Angiotensin System

Brasier, Allan R., Recinos, Adrian, Eledrisi, Mohsen S.·2002·Arteriosclerosis, Thrombosis, and Vascular Biology

DOI 10.1161/01.atv.0000021412.56621.a2

Open this paper in CoChat — free account

Abstract

It is now well established that vascular inflammation is an independent risk factor for the development of atherosclerosis. In otherwise healthy patients, chronic elevations of circulating interleukin-6 or its biomarkers are predictors for increased risk in the development and progression of ischemic heart disease. Although multifactorial in etiology, vascular inflammation produces atherosclerosis by the continuous recruitment of circulating monocytes into the vessel wall and by contributing to an oxidant-rich inflammatory milieu that induces phenotypic changes in resident (noninflammatory) cells. In addition, the renin-angiotensin system (RAS) has important modulatory activities in the atherogenic process. Recent work has shown that angiotensin II (Ang II) has significant proinflammatory actions in the vascular wall, inducing the production of reactive oxygen species, inflammatory cytokines, and adhesion molecules. These latter effects on gene expression are mediated, at least in part, through the cytoplasmic nuclear factor-kappaB transcription factor. Through these actions, Ang II augments vascular inflammation, induces endothelial dysfunction, and, in so doing, enhances the atherogenic process. Our recent studies have defined a molecular mechanism for a biological positive-feedback loop that explains how vascular inflammation can be self-sustaining through upregulation of the vessel wall Ang II tone. Ang II produced locally by the inflamed vessel induces the synthesis and…

Integrity signals

Registry

Crossref · 10.1161/01.atv.0000021412.56621.a2

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.
Rajagopalan, S., Kurz, S. D., Münzel, T. F., Tarpey, M. M., Freeman, B. Α., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,467
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429

Show all 126 references

Research works printed but not linked: 63

10.1161/circ.104.3.365 · DOI
2000, Pharmacol Rev, 52, 11
10.1161/hyp.37.4.1047 · DOI
10.1161/circ.90.4.7923656 · DOI
1993, Arterioscler Thromb Vasc Biol, 12, 1125
1992, J Cardiovasc Pharmacol, 20, 38
10.1161/hyp.30.3.371 · DOI
10.1161/hyp.30.5.1183 · DOI
10.1161/circ.94.3.240 · DOI
10.1161/circ.101.14.1653 · DOI
10.1161/circ.101.20.2349 · DOI
10.1161/circ.101.13.1586 · DOI
2001, J Cardiovasc Pharmacol, 28, 395
10.1161/hyp.34.4.969 · DOI
1997, Lab Invest, 76, 835
10.1161/circ.103.3.448 · DOI
2001, J Clin Invest, 105, 1605
10.1161/res.74.6.8187280 · DOI
10.1161/circ.99.15.2027 · DOI
2001, Mol Cell Biochem, 212, 155
10.1161/hyp.29.1.366 · DOI
10.1161/res.87.12.1195 · DOI
10.1161/res.86.5.494 · DOI
10.1161/atvb.20.10.2175 · DOI
10.1161/res.88.9.888 · DOI
10.1161/atvb.21.9.1464 · DOI
10.1161/circ.100.9.899 · DOI
10.1161/atvb.20.3.645 · DOI
10.1161/circ.100.15.1646 · DOI
10.1161/circ.100.11.1223 · DOI
10.1161/circ.95.6.1532 · DOI
10.1161/res.84.6.695 · DOI
10.1161/atvb.19.7.1623 · DOI
1998, Nature, 294, 894
1991, Am J Physiol, 260, H1713
1996, Mol Endocrinol, 10, 252
10.1161/circ.99.16.2079 · DOI
10.1161/circ.101.15.1767 · DOI
2001, N Engl J Med, 342, 836
10.1161/circ.98.8.731 · DOI
10.1161/circ.97.5.425 · DOI
10.1161/atvb.17.6.1121 · DOI
10.1161/circ.99.2.237 · DOI
10.1161/circ.101.3.252 · DOI
2001, BMJ, 321, 199
2001, Eur Heart J, 21, 1584
10.1161/circ.97.20.2007 · DOI
10.1210/mend.16.4.0811 · DOI
1995, Ann N Y Acad Sci, 762, 12
10.1210/mend.15.3.0609 · DOI
Brasier AR Recinos AI Eledrisi MS. Mechanisms for vascular inflammation as a cardiovascular risk factor.In: Runge M Patterson C eds. Principles of Molecular Cardiology. Totowa NJ: Humana Press; 2002.
1998, Endocrinology, 121, 1616
10.1161/circ.103.9.1194 · DOI
10.1161/circ.103.21.2531 · DOI
10.1161/circ.102.18.2165 · DOI
1997, Endocr Rev, 18, 662
1998, Nat Genet, 4, 59
10.3109/00365518709168886 · DOI
10.1161/res.57.2.3893789 · DOI
1975, J Reticuloendothel Soc, 17, 319
10.1161/circ.94.11.2756 · DOI
10.1161/circ.101.12.1372 · DOI
1997, Eur J Med Res, 2, 285

Sorted by citations

IL-6 in inflammation, autoimmunity and cancer
Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453
“The AngII–AT1R axis activates the NF-κ B pathway through various growth factors and pro-inflammatory cytokines (347, 348).”
Background
Inflammatory cytokines in vascular dysfunction and vascular disease
Sprague, A. H., & Khalil, R. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.029 · Cited by 1,381
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R. G., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,135
C-Reactive Protein and the Risk of Developing Hypertension
Sesso, H. D. (2003) · JAMA · doi:10.1001/jama.290.22.2945 · Cited by 1,013
Inflammation in Heart Failure
Murphy, S., Kakkar, R. K., McCarthy, C. P., & Januzzi, J. L. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.01.014 · Cited by 791
Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans
Vincent, H. K., & Taylor, A. G. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803177 · Cited by 752
Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins
Casserly, I., & Topol, E. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15900-x · Cited by 560
Inflammation in Hypertension
Xiao, L., & Harrison, D. G. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.01.013 · Cited by 557
The NF-κB Regulatory Network
Brasier, A. R. (2006) · Cardiovascular Toxicology · doi:10.1385/ct:6:2:111 · Cited by 533
Self-citation
ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome
Devaux, C. A., Rolain, J., & Raoult, D. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.04.015 · Cited by 483
Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity
Hansel, B., Giral, P., Nobécourt, E., Chantepie, S., Bruckert, É., Chapman, M. J., & Kontush, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0305 · Cited by 476
Interleukin-6 Induces Oxidative Stress and Endothelial Dysfunction by Overexpression of the Angiotensin II Type 1 Receptor
Waßmann, S., Stumpf, M., Strehlow, K., Schmid, A., Schieffer, B., Böhm, M., & Nickenig, G. (2003) · Circulation Research · doi:10.1161/01.res.0000115557.25127.8d · Cited by 476
An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice
Tieu, B. C., Lee, C., Sun, H., LeJeune, W. S., Recinos, A., Ju, X., Spratt, H. M., Guo, D., Milewicz, D. M., Tilton, R. G., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38308 · Cited by 474
Self-citation
Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans
Morrow, J. D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000152605.64964.c0 · Cited by 449
Angiotensin receptors: a new role in cancer?
Deshayes, F., & Nahmias, C. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.07.009 · Cited by 437
Role of the renin–angiotensin system in vascular inflammation
Marchesi, C., Paradis, P., & Schiffrin, E. L. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.05.003 · Cited by 432
C-reactive protein and the risk of developing hypertension
Sesso, H. D., Buring, J. E., Rifai, N., Blake, G., Gaziano, J. M., & Ridker, R. M. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.02.025 · Cited by 430
Aortic Dissection Precedes Formation of Aneurysms and Atherosclerosis in Angiotensin II-Infused, Apolipoprotein E-Deficient Mice
Saraff, K., Babamusta, F., Cassis, L. A., & Daugherty, A. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000085631.76095.64 · Cited by 431
Inflammation in the genesis and perpetuation of atrial fibrillation
Engelmann, M. D. M., & Svendsen, J. H. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi350 · Cited by 421
JCS/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease
Fukazawa, R., Kobayashi, J., Ayusawa, M., Hamada, H., Miura, M., Mitani, Y., Tsuda, E., Nakajima, H., Matsuura, H., Ikeda, K., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-19-1094 · Cited by 421
Antiinflammatory Effects of Angiotensin II Subtype 1 Receptor Blockade in Hypertensive Patients With Microinflammation
Fliser, D., Buchholz, K., & Haller, H. G. (2004) · Circulation · doi:10.1161/01.cir.0000140265.21608.8e · Cited by 410
The metabolic syndrome: role of skeletal muscle metabolism.
Stump, C. S., Henriksen, E. J., Wei, Y., & Sowers, J. R. (2006) · Annals of Medicine · doi:10.1080/07853890600888413 · Cited by 362
Reduced Vascular Remodeling, Endothelial Dysfunction, and Oxidative Stress in Resistance Arteries of Angiotensin II–Infused Macrophage Colony-Stimulating Factor–Deficient Mice
Ciuceis, C. D., Amiri, F., Brassard, P., Endemann, D., Touyz, R. M., & Schiffrin, E. L. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000181743.28028.57 · Cited by 354
COVID-19 – A vascular disease
Siddiqi, H. K., Libby, P., & Ridker, P. M. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.10.005 · Cited by 347
Obesity and Thrombosis
Darvall, K., Sam, R. C., Silverman, S., Bradbury, A. W., & Adam, D. J. (2006) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2006.10.006 · Cited by 337
Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases
Vona, R., Gambardella, L., Cittadini, C., Straface, E., & Pietraforte, D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8267234 · Cited by 353
Progenitor/stem cells give rise to liver cancer due to aberrant TGF-β and IL-6 signaling
Tang, Y., Kitisin, K., Jogunoori, W. S., Li, C., Deng, C., Mueller, S. C., Ressom, H. W., Rashid, A., He, A. R., Mendelson, J. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705395105 · Cited by 314
Angiotensin II Induces Premature Senescence of Vascular Smooth Muscle Cells and Accelerates the Development of Atherosclerosis via a p21-Dependent Pathway
Kunieda, T., Minamino, T., Nishi, J.-I., Tateno, K., Oyama, T., Katsuno, T., Miyauchi, H., Orimo, M., Okada, S., Takamura, M., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.626606 · Cited by 302
Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification
Doherty, T. M., Fitzpatrick, L. A., Inoue, D., Qiao, J.-H., Fishbein, M. C., Detrano, R., Shah, P. K., & Rajavashisth, T. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0015 · Cited by 299
Roles of Oxidative Stress and Inflammation in Vascular Endothelial Dysfunction-Related Disease
Higashi, Y. (2022) · Antioxidants · doi:10.3390/antiox11101958 · Cited by 326
Systemic inflammation in heart failure – The whys and wherefores
Yndestad, A., Kristian Damås, J., Øie, E., Ueland, T., Gullestad, L., & Aukrust, P. (2006) · Heart Failure Reviews · doi:10.1007/s10741-006-9196-2 · Cited by 294
Associations between body mass index and the prevalence of low micronutrient levels among US adults.
Kimmons, J. E., Blanck, H. M., Tohill, B. C., Zhang, J., & Khan, L. K. (2006) · PubMed Central · Cited by 290
Inflammation in hypertension
Savoia, C., & Schiffrin, E. L. (2006) · Current Opinion in Internal Medicine · doi:10.1097/01.mnh.0000203189.57513.76 · Cited by 287
Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis
Kisseleva, T., & Brenner, D. A. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04658.x · Cited by 291
C‐Reactive Protein (CRP)‐Lowering Agents
Prasad, K. (2006) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2006.00033.x · Cited by 274
Novel Long Noncoding RNAs Are Regulated by Angiotensin II in Vascular Smooth Muscle Cells
Leung, A., Trac, C., Jin, W. L., Lanting, L. L., Akbany, A., Sætrom, P., Schones, D. E., & Natarajan, R. D. (2013) · Circulation Research · doi:10.1161/circresaha.112.300849 · Cited by 268
Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species
Wei, Y., Chen, K., Whaley‐Connell, A. T., Stump, C. S., Ibdah, J. A., & Sowers, J. R. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00561.2007 · Cited by 270
Postischemic Revascularization: From Cellular and Molecular Mechanisms to Clinical Applications
Silvestre, J., Smadja, D. M., & Levy, B. I. (2013) · Physiological Reviews · doi:10.1152/physrev.00006.2013 · Cited by 281
From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension
Schiffrin, E. L., & Touyz, R. M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00262.2004 · Cited by 255
Redox‐dependent signalling by angiotensin II and vascular remodelling in hypertension
Touyz, R. M., Tabet, F., & Schiffrin, E. L. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03930.x · Cited by 242
Vascular Mechanobiology: Homeostasis, Adaptation, and Disease
Humphrey, J. D., & Schwartz, M. A. (2021) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-092419-060810 · Cited by 242
NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases
Fiordelisi, A., Iaccarino, G., Morisco, C., Coscioni, E., & Sorriento, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071599 · Cited by 219
Ras Induces Vascular Smooth Muscle Cell Senescence and Inflammation in Human Atherosclerosis
Minamino, T., Yoshida, T., Tateno, K., Miyauchi, H., Zou, Y., Toko, H., & Komuro, I. (2003) · Circulation · doi:10.1161/01.cir.0000093274.82929.22 · Cited by 208
Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis—a randomized study
Takahashi, A., Takase, H., Toriyama, T., Sugiura, T., Kurita, Y., Ueda, R., & Dohi, Y. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl293 · Cited by 205
Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II – editorial review
Touyz, R. M. (2005) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200503000-00007 · Cited by 207
Oxidized Low-Density Lipoprotein and Atherosclerosis Implications in Antioxidant Therapy
Mitra, S., Deshmukh, A. J., Sachdeva, R., Lü, J., & Mehta, J. L. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318224a147 · Cited by 197
Curcumin as a natural regulator of monocyte chemoattractant protein-1
Karimian, M. S., Pirro, M., Majeed, M. A., & Sahebkar, A. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.10.001 · Cited by 197
Inflammation as a Regulator of the Renin-Angiotensin System and Blood Pressure
Satou, R., Penrose, H. M., & Navar, L. G. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0900-0 · Cited by 201
Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology
Eguchi, S., Kawai, T., Scalia, R., & Rizzo, V. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.10266 · Cited by 189
C-reactive protein and interleukin-6 in vascular disease
Rattazzi, M., Puato, M., Faggin, E., Bertipaglia, B., Zambon, A., & Pauletto, P. (2003) · Journal of Hypertension · doi:10.1097/00004872-200310000-00002 · Cited by 180
Multiple Biomarkers and the Risk of Incident Hypertension
Wang, T. J., Gona, P. N., Larson, M. G., Levy, D. A., Benjamin, E. J., Tofler, G. H., Jacques, P. F., Meigs, J. B., Rifai, N., Selhub, J., et al. (2007) · Hypertension · doi:10.1161/01.hyp.0000256956.61872.aa · Cited by 179
Role of inflammation in the progression of heart failure
Yndestad, A., Damås, J. K., Øie, E., Ueland, T., Gullestad, L. L., & Aukrust, P. (2007) · Current Cardiology Reports · doi:10.1007/bf02938356 · Cited by 177
Diastolic Dysfunction in Hypertensive Hearts: Roles of Perivascular Inflammation and Reactive Myocardial Fibrosis
Kai, H., Kuwahara, F., Tokuda, K., & Imaizumi, T. (2005) · Hypertension Research · doi:10.1291/hypres.28.483 · Cited by 174
A Review on Medicinal Properties of Orientin
Lam, K. Y., Ling, A. P. K., Koh, R. Y., Wong, Y. P., & Say, Y. (2016) · Advances in Pharmacological Sciences · doi:10.1155/2016/4104595 · Cited by 178
Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension
Navar, L. G., Prieto, M. C., Satou, R., & Kobori, H. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.01.009 · Cited by 169
The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction
Schmaier, A. H. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00535.2002 · Cited by 170
Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct–ligated rats†
Bataller, R. A., Gäbele, E., Parsons, C. J., Morris, T., Yang, L., Schoonhoven, R., Brenner, D. A., & Rippe, R. A. (2005) · Hepatology · doi:10.1002/hep.20665 · Cited by 166
Bone Marrow–Derived Monocyte Chemoattractant Protein-1 Receptor CCR2 Is Critical in Angiotensin II–Induced Acceleration of Atherosclerosis and Aneurysm Formation in Hypercholesterolemic Mice
Ishibashi, M., Egashira, K., Zhao, Q. D., Hiasa, K., Ohtani, K., Ihara, Y., Charo, I. F., Kura, S., Tsuzuki, T., Takeshita, A., et al. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000143384.69170.2d · Cited by 162
Inflammation in heart failure: pathophysiology and therapeutic strategies
Boulet, J., Sridhar, V. S., Bouabdallaoui, N., Tardif, J., & White, M. (2024) · Inflammation Research · doi:10.1007/s00011-023-01845-6 · Cited by 173
Psychological stress activates interleukin-1β gene expression in human mononuclear cells
Brydon, L., Edwards, S., Jia, H., Mohamed-Ali, V., Zachary, I., Martin, J. F., & Steptoe, A. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2004.12.003 · Cited by 159
Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study
Maruhashi, T., Soga, J., Fujimura, N., Idei, N., Mikami, S., Iwamoto, Y., Kajikawa, M., Matsumoto, T., Hidaka, T., Kihara, Y., et al. (2013) · Heart · doi:10.1136/heartjnl-2013-304739 · Cited by 159
Dietary carbohydrate intake is associated with cardiovascular disease risk in Korean: Analysis of the third Korea National Health and Nutrition Examination Survey (KNHANES III)
Park, S.-H., Lee, K.-S., & Park, H. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.10.011 · Cited by 155
Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: Therapeutic implications for cardiovascular diseases
Tousoulis, D., Andreou, I., Antoniades, C. A., Tentolouris, C. A., & Stefanadis, C. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.034 · Cited by 157
Renal and vascular hypertension-induced inflammation: role of angiotensin II
Ruiz‐Ortega, M., Esteban, V., Rupérez, M., Sánchez‐López, E., Rodríguez‐Vita, J., Carvajal, G., & Egido, J. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000203190.34643.d4 · Cited by 155
Effects of Angiotensin-Converting Enzyme Inhibitor Therapy on Clinical Outcome in Patients Undergoing Coronary Artery Bypass Grafting
Miceli, A., Capoun, R., Fino, C., Narayan, P., Bryan, A. J., Angelini, G. D., & Caputo, M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.008 · Cited by 153
Inflammation and Hypertension: The Interplay of Interleukin-6, Dietary Sodium, and the Renin-Angiotensin System in Humans
Chamarthi, B., Williams, G. H., Ricchiuti, V., Srikumar, N., Hopkins, P. N., Luther, J. M., Jeunemaı̂tre, X., & Thomas, A. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.113 · Cited by 158
Vascular cell senescence and vascular aging
Minamino, T., Miyauchi, H., Yoshida, T., Tateno, K., Kunieda, T., & Komuro, I. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.11.010 · Cited by 153
Roles of IL-6-gp130 Signaling in Vascular Inflammation
Hou, T., Tieu, B. C., Ray, S., Recinos, A., Cui, R., Tilton, R. G., & Brasier, A. R. (2008) · Current Cardiology Reviews · doi:10.2174/157340308785160570 · Cited by 149
Self-citation
Valsartan, Blood Pressure Reduction, and C-Reactive Protein
Ridker, P. M., Danielson, E., Rifai, N., & Glynn, R. J. (2006) · Hypertension · doi:10.1161/01.hyp.0000226046.58883.32 · Cited by 148
The role of angiotensin II in regulating vascular structural and functional changes in hypertension
Touyz, R. M. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0073-2 · Cited by 145
Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome
Skalický, J., Mužáková, V., Kanďár, R., Milan Meloun, A., Roušar, T., & Palička, V. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.096 · Cited by 142
Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver
Bataller, R. A., Gäbele, E., Schoonhoven, R., Morris, T., Lehnert, M., Yang, L., Brenner, D. A., & Rippe, R. A. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00037.2003 · Cited by 144
Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy
Jiang, Y.-Z., Rubin, L., Peng, T., Liu, L., Xing, X., Lazarovici, P., & Zheng, W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59272 · Cited by 144
Pro-inflammatory cytokines in acute coronary syndromes: From bench to bedside
Tousoulis, D., Antoniades, C., Koumallos, N., & Stefanadis, C. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.04.003 · Cited by 139
Role of the renin–angiotensin–aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction
Sciarretta, S., Paneni, F., Palano, F., Chin, D., Tocci, G., Rubattu, S., & Volpe, M. (2009) · Clinical Science · doi:10.1042/cs20080390 · Cited by 140
Inflammatory Responses Underlying the Microvascular Dysfunction Associated with Obesity and Insulin Resistance
Singer, G., & Granger, N. D. (2007) · Microcirculation · doi:10.1080/10739680701283158 · Cited by 140
Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress
Spahis, S., Borys, J.-M., & Levy, E. H. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6756 · Cited by 142
Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: a literature review
von Frankenberg, A. D., Reis, A. F., & Gerchman, F. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000316 · Cited by 147
A Role of Matrix Metalloproteinase-8 in Atherosclerosis
Laxton, R. C., Hu, Y., Duchêne, J., Zhang, F., Zhang, Z., Leung, K., Xiao, Q., Scotland, R. S., Hodgkinson, C. P., Smith, K., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.200279 · Cited by 141
Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation
Zhang, G., LU, X., KIMURA, S., & Nishiyama, A. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.07.014 · Cited by 134
The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer
Major, T. C., Brant, D. O., Reynolds, M. M., Bartlett, R. H., Meyerhoff, M. E., Handa, H., & Annich, G. M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.12.028 · Cited by 135
Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib and Off-Target Toxicity
Vergeer, M., Bots, M. L., van Leuven, S. I., Basart, D. C. G., Sijbrands, E. J. G., Evans, G. W., Grobbee, D. E., Visseren, F. L. J., Stalenhoef, A. F. H., Stroes, E. S. G., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.772665 · Cited by 133
The Potential Influence of Inflammation and Insulin Resistance on the Pathogenesis and Treatment of Atherosclerosis-Related Complications in Type 2 Diabetes
Dandona, P., Aljada, A., Chaudhuri, A., & Bandyopadhyay, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030178 · Cited by 129
STAT3 NH2-Terminal Acetylation Is Activated by the Hepatic Acute-Phase Response and Required for IL-6 Induction of Angiotensinogen
Ray, S., Boldogh, I. R., & Brasier, A. R. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.07.055 · Cited by 131
Self-citation
Inflammation in venous thromboembolism: Cause or consequence?
Saghazadeh, A., Hafizi, S., & Rezaei, N. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.07.044 · Cited by 128
Effect of AT 1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-κB/IκB system
Sanz‐Rosa, D., Oubiña, M. P., Cediel, E., Heras, N. D. L., Vegazo, O., Jiménez, J., Lahera, V., & Cachofeiro, V. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01061.2003 · Cited by 125
Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice
Gao, P., Xu, T., Lu, J., Li, L., Xu, J., Hao, D., Chen, H., & Liu, D. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1111-4 · Cited by 127
Angiotensin-Converting Enzyme Inhibitor Use Is Associated With Reduced Plasma Concentration of C-Reactive Protein in Patients With First-Ever Ischemic Stroke
Napoli, M. D., & Papa, F. (2003) · Stroke · doi:10.1161/01.str.0000099124.84425.bb · Cited by 121
Association of Leukocyte Telomere Length With Circulating Biomarkers of the Renin-Angiotensin-Aldosterone System
Vasan, R. S., Demissie, S., Kimura, M., Cupples, L. A., Rifai, N., White, C. C., Wang, T. J., Gardner, J. P., Cao, X., Benjamin, E. J., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.731794 · Cited by 122
Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice
Recinos, A., LeJeune, W. S., Sun, H., Lee, C. Y., Tieu, B. C., Lu, M., Hou, T., Boldogh, I. R., Tilton, R. G., & Brasier, A. R. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.10.013 · Cited by 120
Self-citation
Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats
Wei, Y., Clark, S. E., Morris, E. M., Thyfault, J. P., Uptergrove, G. M., Whaley‐Connell, A. T., Ferrario, C. M., Sowers, J. R., & Ibdah, J. A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.018 · Cited by 121
Pressure-Independent Effects of Angiotensin II on Hypertensive Myocardial Fibrosis
Tokuda, K., Kai, H., Kuwahara, F., Yasukawa, H., Tahara, N., Kudo, H., Takemiya, K., Koga, M., Yamamoto, T., & Imaizumi, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000111831.50834.93 · Cited by 115
Adiponectin: an adipokine with protective features against metabolic syndrome.
Esfahani, M., Movahedian, A., Baranchi, M., & Goodarzi, M. T. (2015) · Europe PMC (PubMed Central) · Cited by 111
Models for the study of skin wound healing. The role of Nrf2 and NF-κB
Ambrožová, N., Ulrichová, J., & Galandáková, A. (2017) · Biomedical Papers · doi:10.5507/bp.2016.063 · Cited by 118
Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF
Yamagishi, S., Nakamura, K., Ueda, S., Kato, S., & Imaizumi, T. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-1094-8 · Cited by 110
The autoimmune origin of atherosclerosis
Blasi, C. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.025 · Cited by 109
Long noncoding RNA p21 enhances autophagy to alleviate endothelial progenitor cells damage and promote endothelial repair in hypertension through SESN2/AMPK/TSC2 pathway
Li, C., Lin, L., Zhang, L., Xu, R., Chen, X., Ji, J., & Li, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105920 · Cited by 108
Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells
Das, S., Senapati, P., Chen, Z., Reddy, M. A., Ganguly, R., Lanting, L. L., Mandi, V., Bansal, A., Leung, A., Zhang, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01629-7 · Cited by 105
The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA)
Lakoski, S. G., Cushman, M., Siscovick, D. S., Blumenthal, R. S., Palmas, W., Burke, G. L., & Herrington, D. M. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.91 · Cited by 105
NADPH Oxidase Contributes to Vascular Inflammation, Insulin Resistance, and Remodeling in the Transgenic (mRen2) Rat
Wei, Y., Whaley‐Connell, A. T., Chen, K., Habibi, J., Uptergrove, G. M., Clark, S. E., Stump, C. S., Ferrario, C. M., & Sowers, J. R. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.089284 · Cited by 106

Authors: Brasier, A. R., Recinos, A., & Eledrisi, M. S.
Affiliations: The University of Texas Medical Branch at Galveston (US)
From the Departments of Medicine (A.R.B., A.R., M.S.E.) and Human Biological Chemistry and Genetics (A.R.B.) and the Sealy Center for Molecular Sciences (A.R.B.), The University of Texas Medical Branch, Galveston.
ORCID: Brasier, Allan R.
Eledrisi, Mohsen S.
Venue: Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2002-08
Volume: 22
Issue: 8
Pages: 1257-1266
ISSN: 1079-5642 (ISSN-L)
1524-4636
DOI: 10.1161/01.atv.0000021412.56621.a2
OpenAlex: W2154360613
Cited by: 586
References: 126
Citations by year: 2026: 4 · 2025: 17 · 2024: 12 · 2023: 16 · 2022: 9 · 2021: 20 · 2020: 21 · 2019: 12 · 2018: 16 · 2017: 22 · 2016: 24 · 2015: 22 · 2014: 25 · 2013: 22 · 2012: 29
FWCI: 5.16
Type: journal article
Language: en
Open access: closed
Locations: Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (55630)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Keywords: vascular inflammation, renin-angiotensin system, angiotensin II, atherosclerosis, interleukin-6, nuclear factor-kappaB, JAK/STAT3 signaling, angiotensinogen, oxidized lipids, endothelial dysfunction, monocyte recruitment, reactive oxygen species, ischemic heart disease
MeSH terms: Acute-Phase Proteins, Angiotensin II, Animals, Arteriosclerosis, Endothelium, Vascular, Humans, Inflammation, Cholesterol, LDL, Liver, Macrophages, Monocytes, Oxidation-Reduction, Renin-Angiotensin System, Signal Transduction, Interleukin-6, Reactive Oxygen Species, Feedback, Physiological

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vascular Inflammation and the Renin-Angiotensin System

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks